Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
03 janv. 2024 08h30 HE
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference
02 août 2023 16h05 HE
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
BioNTech präsentiert auf der 41. Annual J.P. Morgan Healthcare Conference
28 déc. 2022 06h45 HE
|
BioNTech SE
MAINZ, Deutschland, 28. Dezember 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, dass CEO und Mitbegründer Prof. Dr. Ugur Sahin ein...
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
28 déc. 2022 06h45 HE
|
BioNTech SE
Mainz, Germany, December 28, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Prof. Ugur Sahin, M.D., will present a corporate...
BioNTech veröffentlicht am 9. Mai 2022 Ergebnisse des ersten Quartals sowie Informationen zum operativen Fortschritt
26 avr. 2022 07h00 HE
|
BioNTech SE
MAINZ, Deutschland, 26. April 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 9. Mai 2022, die Ergebnisse des ersten Quartals 2022...
BioNTech to Report First Quarter 2022 Financial Results and Operational Update on May 9, 2022
26 avr. 2022 07h00 HE
|
BioNTech SE
Mainz, Germany, April 26, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2022 on Monday, May 9th, 2022....
Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference
06 avr. 2022 07h30 HE
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs to treat age-related degenerative diseases of...
BioNTech veröffentlicht am 30. März 2022 Ergebnisse des Geschäftsjahres 2021 und informiert zum operativen Fortschritt im vierten Quartal
16 mars 2022 09h00 HE
|
BioNTech SE
MAINZ, DEUTSCHLAND, 16. März 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Mittwoch, den 30. März 2022, die Ergebnisse des Geschäftsjahres sowie des...
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
16 mars 2022 09h00 HE
|
BioNTech SE
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2021 on Wednesday,...
BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
09 août 2021 07h00 HE
|
BioNTech SE
More than one billion doses of BNT162b2 vaccine supplied to more than 100 countries or territories worldwide as of July 21, 2021Signed agreements for approximately 2.2 billion doses of BNT162b2 in...